Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-04-14

Clinical Trial Update: Intravenous Dexmedetomidine for Emergence Delirium in Pediatric Patient [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update investigating intravenous dexmedetomidine for emergence delirium in pediatric patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dexmedetomidine (Dexmedetomidine)

Snippet

Sponsor: Security Forces Hospital | Conditions: Emergence Delirium, Dexmeditomidine | Phase 4 | Status: UNKNOWN